Security Snapshot

Orthofix Medical Inc. - Common Stock (OFIX) Institutional Ownership

CUSIP: 68752M108

13F Institutional Holders and Ownership History from Q1 2018 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

142

Shares (Excl. Options)

35,152,622

Price

$15.16

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
OFIX on Nasdaq
Shares outstanding
39,581,465
Price per share
$11.47
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
35,152,622
Total reported value
$532,914,571
% of total 13F portfolios
0%
Share change
-55,584
Value change
-$494,427
Number of holders
142
Price from insider filings
$11.47
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • OFIX - Orthofix Medical Inc. - Common Stock is tracked under CUSIP 68752M108.
  • 142 institutions reported positions in Q4 2025.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 142 to 10 between Q4 2025 and Q1 2026.
  • Reported value moved from $532,914,571 to $293,017.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 142 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 68752M108?
CUSIP 68752M108 identifies OFIX - Orthofix Medical Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Orthofix Medical Inc. - Common Stock (OFIX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ENGINE CAPITAL, L.P. 11% +18% $60,331,211 +$8,846,670 4,251,671 +17% Engine Capital Management, LP 07 May 2025
Juniper Investment Company, LLC 9.6% +18% $57,715,409 +$8,255,328 3,784,617 +17% Juniper Investment Company, LLC 11 Feb 2026
BlackRock, Inc. 7.7% $42,416,393 2,989,175 BlackRock, Inc. 31 Mar 2025
ARMISTICE CAPITAL, LLC 6.7% +17% $40,382,000 +$6,283,000 2,648,000 +18% Armistice Capital, LLC 31 Dec 2025

As of 31 Dec 2025, 142 institutional investors reported holding 35,152,622 shares of Orthofix Medical Inc. - Common Stock (OFIX). This represents 89% of the company’s total 39,581,465 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Orthofix Medical Inc. - Common Stock (OFIX) together control 81% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Engine Capital Management, LP 11% 4,252,921 0% 8.9% $64,474,282
Rubric Capital Management LP 9.4% 3,721,715 0% 0.67% $56,421,199
Juniper Investment Company, LLC 8.9% 3,510,333 +23% 18% $53,216,648
PARADIGM CAPITAL MANAGEMENT INC/NY 8.3% 3,304,899 -1.2% 2.1% $50,102,269
BlackRock, Inc. 7.9% 3,139,838 +0.07% 0% $47,599,943
ARMISTICE CAPITAL, LLC 6.7% 2,648,000 +18% 0.98% $40,143,680
VANGUARD GROUP INC 5.8% 2,304,928 +0.98% 0% $34,942,708
MILLENNIUM MANAGEMENT LLC 3.6% 1,441,267 -2.3% 0.02% $21,849,608
Philosophy Capital Management LLC 2.6% 1,015,194 +15% 1.8% $15,390,341
DIMENSIONAL FUND ADVISORS LP 2.4% 949,087 -17% 0% $14,388,756
GEODE CAPITAL MANAGEMENT, LLC 2.4% 947,189 +0.62% 0% $14,362,333
STATE STREET CORP 2.2% 857,690 -1.7% 0% $13,002,580
AYAL Capital Advisors Ltd 1.9% 742,372 -11% 6.2% $11,254,360
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.84% 333,805 -0.59% 0% $5,060,484
Nuveen, LLC 0.84% 332,042 -38% 0% $5,033,757
NORTHERN TRUST CORP 0.81% 318,646 -7.3% 0% $4,830,674
BANK OF AMERICA CORP /DE/ 0.66% 261,386 -12% 0% $3,962,611
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.65% 256,094 -18% 0% $3,882,385
JPMORGAN CHASE & CO 0.6% 237,273 -8% 0% $3,597,058
GABELLI FUNDS LLC 0.59% 235,303 +0.43% 0.02% $3,567,193
ACADIAN ASSET MANAGEMENT LLC 0.57% 226,590 +33% 0.01% $3,432,000
MORGAN STANLEY 0.57% 224,642 +30% 0% $3,405,571
GOLDMAN SACHS GROUP INC 0.53% 211,419 -26% 0% $3,205,112
TUDOR INVESTMENT CORP ET AL 0.51% 202,606 -6.7% 0.02% $3,071,507
Russell Investments Group, Ltd. 0.5% 197,930 +4.3% 0% $3,000,614

Institutional Holders of Orthofix Medical Inc. - Common Stock (OFIX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 25,545 $293,017 -$24,318 $11.47 10
2025 Q4 35,152,622 $532,914,571 -$494,427 $15.16 142
2025 Q3 35,209,561 $515,431,059 -$6,954,850 $14.64 142
2025 Q2 35,918,321 $400,488,868 +$22,756,116 $11.15 156
2025 Q1 33,187,409 $541,283,546 +$2,357,038 $16.31 158
2024 Q4 33,046,769 $576,999,751 -$25,102,994 $17.46 149
2024 Q3 34,675,214 $541,637,314 -$18,041,209 $15.62 148
2024 Q2 35,567,022 $471,619,624 -$3,810,664 $13.26 129
2024 Q1 35,794,867 $519,708,553 +$407,953 $14.52 136
2023 Q4 35,824,640 $482,922,201 +$19,451,575 $13.48 154
2023 Q3 34,171,175 $439,457,256 +$12,134,957 $12.86 159
2023 Q2 33,051,411 $596,926,163 +$9,962,445 $18.06 148
2023 Q1 32,569,069 $545,548,927 +$197,201,126 $16.75 160
2022 Q4 20,484,051 $420,501,877 +$16,183,620 $20.53 152
2022 Q3 19,713,019 $376,732,898 -$5,543,784 $19.11 139
2022 Q2 19,816,453 $466,601,660 +$6,575,599 $23.54 127
2022 Q1 19,416,935 $634,819,749 -$541,500 $32.70 146
2021 Q4 19,450,587 $604,233,953 -$9,830,363 $31.09 131
2021 Q3 19,555,033 $746,013,245 +$21,323,967 $38.12 141
2021 Q2 18,994,693 $761,880,787 -$4,418,230 $40.11 134
2021 Q1 19,021,142 $824,356,370 +$2,402,671 $43.35 137
2020 Q4 19,028,176 $817,839,883 +$10,159,437 $42.98 138
2020 Q3 18,800,230 $585,684,972 +$7,467,697 $31.14 132
2020 Q2 18,488,760 $591,010,560 +$1,189,132 $32.00 139
2020 Q1 18,523,626 $518,625,834 -$6,413,507 $28.01 141
2019 Q4 18,572,262 $857,611,846 -$5,131,906 $46.18 150
2019 Q3 18,481,155 $979,844,393 +$21,155,365 $53.02 153
2019 Q2 18,082,971 $956,145,616 +$4,470,817 $52.88 151
2019 Q1 18,397,613 $1,037,760,208 +$14,433,303 $56.41 164
2018 Q4 18,156,699 $953,170,632 -$3,721,577 $52.49 166
2018 Q3 18,196,817 $1,051,927,063 +$1,012,496,995 $57.81 157
2018 Q2 674,286 $38,309,830 +$38,300,000 $56.82 12
2018 Q1 173 $10,169 +$10,169 $58.78 1